The Meredith A. Cowden Foundation in collaboration with The Case Comprehensive Cancer Center, The Seidman Cancer Center of University Hospitals of Cleveland and Cleveland Clinic’s Taussig Cancer Institute, presents the 2013 National GvHD Health Symposium at the Embassy Suites Cleveland-Rockside, 5800 Rockside Woods Blvd., Independence, Ohio on Friday, November 1, 2013, from 8am to 5pm. This unique one-day conference, will consist of two-tracks – one designed for physicians and other health care professionals and one for bone-marrow transplant (BMT) survivors, their families and their caregivers. Both tracks will focus on cutting edge research and new treatments.
Last year, over 150 people attended this unique event providing an opportunity for survivors, their families and caregivers to interact with some of the world’s leading authorities on the cause, treatment and management of Graft vs. Host Disease, a complication that effects over 60% of bone marrow transplant patients. It is the only program of its kind in the United States focusing on this very specific complication.
This year’s Symposium will:
• provide a scientifically rigorous and clinically applicable program to medical providers
• provide programs for mid-level medical professionals and social workers who work with patients, survivors and their families
• present programs specifically to the interests of BMT survivors, their families and their caregivers
• and, bring physicians and patients together to discuss issues, challenges, and successes of dealing with acute and chronic GvHD.
For more information, you may call Shawna Hofstetter, at 216.410.6005 or contact her at email@example.com .